Factors affecting desired participation in transition to an adult life with Duchenne muscular dystrophy (DMD)
Journal of Neuromuscular Diseases · 2025
DOI: 10.1177/22143602251324847 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuromuscular Diseases, 2025. Verfasst von Laura Jb Merkenhof und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Amalia Children's Hospital, Ni…. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Independent Living. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
For people with Duchenne muscular dystrophy (DMD), the transition into their desired adulthood can be challenging.
Objectives
This study aims to; (1) exploring the desired participation for (young) adults with Duchenne muscular dystrophy (DMD); (2) exploration of the view and role of parents in this process; and (3) capturing the gap and the influencing factors between the current and desired situation.
Methods
A cross-sectional digital survey was conducted, based on literature, expert opinion, and interviews with young adults with DMD and their parents. Descriptive and non-parametric statistics were used.
Results
43 adults* with DMD an 30 parents completed the survey. All adults with DMD wanted to have an independent life. They were satisfied with their leisure activities. Gaps between the desired and current situation were identified concerning facilities and aids, social activities, and employment. Important factors of influence on these topics were accessibility, outdoor mobility, adequate care facilities, self-confidence, adequate knowledge of professionals and caregivers, and support of parents. The 30 participating parents saw limited opportunities in accessing facilities and aids, job opportunities, and their son having an intimate relationship.
Conclusions
Adults with DMD desire a meaningful and independent life. The challenges they, and their parents face are mainly on social participation. More focus and collaboration is needed between health care services, social services and occupation environments to empower people with DMD living their desired adult life. *Adults; In this article, we use the term adults. By this we include boys aged 16 and 17.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rehabilitation, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Amalia Children's Hospital, Nijmegen, The Netherlands.
- Department of Rehabilitation, Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
- Duchenne Parent Project, Veenendaal, the Netherlands.
- We Jane, Amsterdam, The Netherlands.
ORCID-Profile: Laura Jb Merkenhof, Saskia Ls Houwen-van Opstal
Zitieren
APA
Merkenhof, L. J., Veenhuizen, Y., Vroom, E., Sterenberg, G., Hesseling, W. C., Groothuis, J. T., Cup, E. H., & Houwen-van Opstal, S. L. (2025). Factors affecting desired participation in transition to an adult life with Duchenne muscular dystrophy (DMD). Journal of Neuromuscular Diseases. https://doi.org/10.1177/22143602251324847
Vancouver
Merkenhof LJ, Veenhuizen Y, Vroom E, Sterenberg G, Hesseling WC, Groothuis JT, et al. Factors affecting desired participation in transition to an adult life with Duchenne muscular dystrophy (DMD). Journal of Neuromuscular Diseases. 2025. doi:10.1177/22143602251324847
BibTeX
@article{Merkenhof2025,
author = {Merkenhof, Laura Jb and Veenhuizen, Yvonne and Vroom, Elizabeth and Sterenberg, Greet and Hesseling, Wendy Chm and Groothuis, Jan T and Cup, Edith H and Houwen-van Opstal, Saskia Ls},
title = {Factors affecting desired participation in transition to an adult life with Duchenne muscular dystrophy (DMD)},
journal = {Journal of Neuromuscular Diseases},
year = {2025},
doi = {10.1177/22143602251324847}
}
EUVIMED